BIOMAT Database Logo BIOMAT Database Logo

[The possibility for treatment of hypertension with dihydroalkaloids of ergot (hydergin)]. 1954

M APPELHANS, and K KAISER, and E WATERLOH, and E WELTE

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D002317 Cardiovascular Agents Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume. Cardioactive Agent,Cardioactive Drug,Cardiovascular Agent,Cardiovascular Drug,Cardioactive Agents,Cardioactive Drugs,Cardiovascular Drugs,Agent, Cardioactive,Agent, Cardiovascular,Drug, Cardioactive,Drug, Cardiovascular
D004876 Ergot Alkaloids Alkaloids originally isolated from the ergot fungus Claviceps purpurea (Hypocreaceae). They include compounds that are structurally related to ergoline (ERGOLINES) and ergotamine (ERGOTAMINES). Many of the ergot alkaloids act as alpha-adrenergic antagonists. Clavine Alkaloids,Alkaloids, Clavine,Alkaloids, Ergot

Related Publications

M APPELHANS, and K KAISER, and E WATERLOH, and E WELTE
[Treatment of hypertension with hydergin].
September 1951, Deutsche medizinische Wochenschrift (1946),
M APPELHANS, and K KAISER, and E WATERLOH, and E WELTE
[Hypertension in old age. Treatment with Hydergin].
October 1983, ZFA. Zeitschrift fur Allgemeinmedizin,
M APPELHANS, and K KAISER, and E WATERLOH, and E WELTE
[Therapy of hypertension with hydergin].
July 1952, Medizinische Monatsschrift,
M APPELHANS, and K KAISER, and E WATERLOH, and E WELTE
[EFFECT OF HYDROGENATED ERGOT ALKALOIDS (HYDERGIN) ON THYROID FUNCTION].
June 1964, Kiserletes orvostudomany,
M APPELHANS, and K KAISER, and E WATERLOH, and E WELTE
[Hydergin therapy of hypertension].
December 1950, Wiener klinische Wochenschrift,
M APPELHANS, and K KAISER, and E WATERLOH, and E WELTE
[Hydergin therapy of hypertension].
July 1954, Arztliche Wochenschrift,
M APPELHANS, and K KAISER, and E WATERLOH, and E WELTE
[Hydrogenated ergot alkaloids (hydergin) in therapy of peripheral circulatory disorders].
October 1951, Deutsche medizinische Wochenschrift (1946),
M APPELHANS, and K KAISER, and E WATERLOH, and E WELTE
[Hydergin in hypertension therapy].
October 1951, Munchener medizinische Wochenschrift (1950),
M APPELHANS, and K KAISER, and E WATERLOH, and E WELTE
Treatment of essential hypertension with the hydrogenated alkaloids of ergot.
January 1953, American practitioner and digest of treatment,
M APPELHANS, and K KAISER, and E WATERLOH, and E WELTE
[Therapy of arterial hypertension by hydergin].
February 1952, Lyon medical,
Copied contents to your clipboard!